Innovent Biologics Archives

China’s Innovent Claims Its GLP-1 Is Superior to Novo Nordisk’s Blockbuster Semaglutide

A major challenge to the global dominance of Novo Nordisk’s blockbuster diabetes and weight-loss drug, semaglutide (sold as Ozempic and Wegovy), has emerged from China. The Chinese pharmaceutical company Innovent Biologics has announced that its proprietary GLP-1 drug demonstrated superior effectiveness in treating Type 2 diabetes compared to Novo Nordisk’s semaglutide. The Basis of the…

China's Innovent signs a $1.14B cancer therapy deal with Japan's Takeda, boosting global oncology research.

China’s Innovent Strikes $1.14 Billion Cancer Drug Deal with Pharma Giant Takeda

Aisha Ajaz3 weeks ago3 weeks ago01 mins

hinese biotech company Innovent Biologics has signed a massive deal with Japan’s Takeda Pharmaceutical. The agreement is valued up to $1.14 billion. This partnership focuses on developing and commercializing a promising new cancer therapy. This collaboration highlights the growing importance of China’s biomedical sector. Innovent will lead the development and regulatory filings in mainland China….